Global News Aggregator
Biogen ‘s new Alzheimer’s treatment could lead to even stronger gains for the biotech company going forward, according to Stifel. Analyst Paul Matteis upgraded shares of the biotech company to…
It’s time to buy Transocean ahead of massive growth for the offshore drilling company, according to Barclays. Analyst J. David Anderson double upgraded shares of Transocean to overweight from underweight,…
It’s time for investors to load up on JinkoSolar shares, according to HSBC. The firm on Wednesday initiated coverage of the solar producer with a buy rating and a $76…
Here are Monday’s biggest calls on Wall Street: Wells Fargo downgrades Adobe to equal weight from overweight Wells said it’s concerned about the high price Adobe paid for design platform…
It’s too soon to determine whether Roblox is a winner in the metaverse, according to Cowen. Analyst Doug Creutz initiated coverage of the online game platform with an underperform rating,…
It’s a good time for investors to stock up on shares of Omnicell as the pharmacy industry turns toward automation, Bank of America says. Analyst Allen Lutz initiated coverage of…
Strong second-quarter results from Moderna make now an opportune time to buy shares of the biotechnology company, Deutsche Bank said. Analyst Emmanuel Papadakis upgraded shares of the Covid-19 vaccine maker…
Here are Tuesday’s biggest calls on Wall Street: Morgan Stanley upgrades NextEra Energy to overweight from equal weight Morgan Stanley said the energy company is a key beneficiary of the…
Markets are underappreciating the multitude of benefits available to First Solar through the Inflation Reduction Act, Bank of America said. Analyst Julien Dumoulin-Smith upgraded shares of the solar stock to…
The top winners of the latest earnings season are large cap companies that are set up to weather a volatile environment, according to Goldman Sachs. The bank named Amazon —…